ESR1 and breast cancer: Although breast cancer patients with PIK3CA mutation harboring primary tumors have prolonged overall survival [9, 11], a recent study revealed that ER+ breast cancer with PIK3CA mutations and reduced survival are associated with three subgroups with amplification at the 17q23, 11q13-14, or 8q24 loci respectively [12].